The conference continues to offer presentations on novel and innovative therapeutics in ocular drug development and discovery. This forum allows for excellent networking, the exchange of ideas, and sharing of challenges; all with a united common goal of bringing new and innovative treatments to patients in the area of ophthalmology.
The conference features the following topics: Session: Novel Targets, Developments and Technologies Session: Novel Drug Delivery Methods to the Anterior and Posterior Segments Session: Clinical Development Advances & Updates Session: Safety Assessment and Regulatory Landscape in Ocular Drug Development Session: Short Presentations Panel Discussion: BD, Investments and Potential for Collaborations Panel Discussion: Safety and Regulatory in Ocular Development The Ocular Diseases & Drug Development Conference promotes the discovery of ocular disease drug development by bringing together leading scientists, researchers and experts to discuss and collaborate on the latest research and development, safety assessment, regulatory issues and drugs in development for combating and curing age-related macular degeneration (AMD), diabetic retinopathy, glaucoma, DME, uveitis and other ocular diseases.
